Lung India


Year
: 2000  |  Volume : 18  |  Issue : 2  |  Page : 50--53

Ipratropium Bromide In COPD Patients Undergoing FOB - Comfort, Complicance And Complications - Pilot Study


V. K Arora1, Sandeep Nayar2, U Uma Shankar3 
1 
2 
3 

Correspondence Address:
V. K Arora


A Pilot study of 10 patients each of COPD in Study group and control group was carried out to find comfort, compliance and complications during bronchoscopy. The results indicate that ipratropium bromide can be considered as another agent for premedication in patients of COPD undergoing bronchocopy.


How to cite this article:
Arora V, Nayar S, Uma Shankar U. Ipratropium Bromide In COPD Patients Undergoing FOB - Comfort, Complicance And Complications - Pilot Study.Lung India 2000;18:50-53


How to cite this URL:
Arora V, Nayar S, Uma Shankar U. Ipratropium Bromide In COPD Patients Undergoing FOB - Comfort, Complicance And Complications - Pilot Study. Lung India [serial online] 2000 [cited 2020 Nov 27 ];18:50-53
Available from: https://www.lungindia.com/article.asp?issn=0970-2113;year=2000;volume=18;issue=2;spage=50;epage=53;aulast=Arora;type=0